Clinical Trial Update: 7 Day Continuous Parathyroid Hormone IV Infusion [EARLY_Phase 1]

View source ↗

Summary

An early-phase trial evaluated a 7-day continuous intravenous infusion of parathyroid hormone. The trial focused on osteoporosis and hyperparathyroidism and has…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperparathyroidism
• Osteoporosis

Drugs mentioned

• Parathyroid hormone (Parathyroid hormone)

Snippet

Sponsor: University of Pittsburgh | Conditions: Osteoporosis, Bone Diseases, Endocrine | EARLY_Phase 1 | Status: COMPLETED | Results posted: 2016-03-22